Reported Consolidated quarterly numbers for Toheal Pharma are:Net Sales at Rs 0.00 crore in March 2023 down 97.6% from Rs. 0.04 crore in March 2022.
Quarterly Net Loss at Rs. 0.01 crore in March 2023 down 160% from Rs. 0.01 crore in March 2022.
EBITDA stands negative at Rs. 0.01 crore in March 2023 down 0% from Rs. 0.00 crore in March 2022.
Toheal Pharm shares closed at 34.44 on June 19, 2023 (BSE) and has given 140.17% returns over the last 6 months and 28.03% over the last 12 months.
| Toheal Pharma | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 0.00 | 0.02 | 0.04 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 0.00 | 0.02 | 0.04 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.01 | 0.01 | 0.01 | | Depreciation | 0.00 | 0.00 | 0.00 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.04 | 0.01 | 0.05 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -0.05 | 0.00 | -0.02 | | Other Income | 0.04 | 0.00 | 0.01 | | P/L Before Int., Excpt. Items & Tax | -0.01 | 0.01 | 0.00 | | Interest | -- | -- | -- | | P/L Before Exceptional Items & Tax | -0.01 | 0.01 | 0.00 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -0.01 | 0.01 | 0.00 | | Tax | 0.00 | 0.00 | -0.02 | | P/L After Tax from Ordinary Activities | -0.01 | 0.01 | 0.01 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.01 | 0.01 | 0.01 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -0.01 | 0.01 | 0.01 | | Equity Share Capital | 9.48 | 9.48 | 9.48 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.01 | 0.01 | 0.01 | | Diluted EPS | -0.01 | 0.01 | 0.01 | | EPS After Extra Ordinary | | Basic EPS | -0.01 | 0.01 | 0.01 | | Diluted EPS | -0.01 | 0.01 | 0.01 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|